Influence of endogenous NEFA on beta cell function in humans

Area of Science:

• Endocrinology
• Metabolic Syndrome
• Diabetes Research

Background:

• Chronic elevation of non-esterified fatty acids (NEFA) is often linked to impaired insulin secretion and action (lipotoxicity).
• Previous research primarily examined acute NEFA elevations, leaving the impact of sustained endogenous NEFA levels on beta cell function under-explored.

Purpose of the Study:

• To investigate the relationship between endogenous NEFA levels and beta cell function.
• To determine if NEFA levels predict the deterioration of glucose tolerance over time.

Main Methods:

• A 3-year follow-up study involving 1,267 individuals.
• Insulin sensitivity was measured using the clamp technique.
• Beta cell function was assessed via C-peptide modeling during oral glucose tolerance tests (OGTT) and acute insulin response (AIR) during intravenous glucose tolerance tests (IVGTT).

Main Results:

• Higher fasting and insulin-suppressed NEFA levels were observed in individuals with varying glucose tolerance, correlating with lower insulin sensitivity.
• While insulin-suppressed NEFA were positively associated with total insulin output after adjusting for insulin sensitivity, neither fasting nor insulin-suppressed NEFA correlated with beta cell glucose sensitivity or AIR.
• Baseline NEFA levels did not predict the worsening of glucose tolerance over the 3-year follow-up period.

Conclusions:

• Endogenous NEFA levels are not independently associated with measures of beta cell function in non-diabetic individuals and those with impaired glucose tolerance.
• The study found no evidence to support beta cell lipotoxicity from endogenous total NEFA concentrations within the RISC cohort.
• Sustained NEFA levels do not appear to predict the progression of glucose intolerance.